mSystems,
Journal Year:
2024,
Volume and Issue:
9(6)
Published: May 3, 2024
ABSTRACT
Acute
ischemic
stroke
(AIS)
patients
with
active
COVID-19
infection
often
have
more
severe
symptoms
and
worse
recovery.
can
cause
gut
microbiota
dysbiosis,
which
is
also
a
risk
factor
for
poor
outcomes
in
AIS
patients.
However,
the
association
between
functional
among
has
not
been
fully
clarified
yet.
In
this
study,
we
performed
16S
rRNA
gene
sequencing
to
characterize
microbial
community
acute
infection,
post-acute
without
infection.
We
found
that
experienced
poorer
recovery
significant
characterized
by
higher
levels
of
Enterobacteriaceae
lower
Ruminococcaceae
Lachnospiraceae
.
Furthermore,
shorter
time
window
(less
than
28
days)
was
identified
as
COVID-19,
enrichment
indicated
mediator
relationship
outcomes.
Our
findings
highlight
importance
early
intervention
after
especially
regulating
microbiota,
plays
role
prognosis
IMPORTANCE
The
an
important
respiratory
system
cerebrovascular
through
gut-lung
axis
gut-brain
axis.
specific
connection
bacteria
understood
our
observed
decrease
bacterial
diversity
shifts
abundance
key
families
critical
influence
outcomes,
acted
research
provides
new
perspective
on
complex
interplay
AIS,
dysbiosis.
Moreover,
recognizing
potential
offers
novel
avenue
future
exploration
therapeutic
interventions.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 8, 2023
The
gut
microbiota
plays
a
crucial
role
in
human
health
and
disease.
Gut
dysbiosis
is
known
to
be
associated
with
increased
susceptibility
respiratory
diseases
modifications
the
immune
response
homeostasis
of
lungs
(the
so-called
gut-lung
axis).
Furthermore,
recent
studies
have
highlighted
possible
neurological
disturbances,
introducing
notion
"gut-brain
axis."
During
last
2
years,
several
described
presence
during
coronavirus
disease
2019
(COVID-19)
its
relationship
severity,
SARS-CoV-2
gastrointestinal
replication,
inflammation.
Moreover,
persistence
after
resolution
may
linked
long-COVID
syndrome
particularly
manifestations.
We
reviewed
evidence
on
association
between
COVID-19,
investigating
epidemiologic
confounding
factors
like
age,
location,
sex,
sample
size,
severity
disease,
comorbidities,
therapy,
vaccination
status
airway
microbial
selected
both
COVID-19
long-COVID.
we
analyzed
strictly
related
microbiota,
specifically
diet
investigation
previous
use
antibiotics/probiotics,
methodology
used
study
(α-
β-diversity
parameters
relative
abundance
tools).
Of
note,
only
few
focused
longitudinal
analyses,
especially
for
long-term
observation
Lastly,
there
lack
knowledge
regarding
transplantation
other
therapeutic
approaches
their
impact
progression
severity.
Preliminary
data
seem
suggest
that
might
play
symptoms.
Indeed,
development
interpretation
these
could
important
implications
future
preventive
strategies.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: March 4, 2022
The
Coronavirus
Disease
2019
(COVID-19)
pandemic
caused
by
Severe
Acute
Respiratory
2
(SARS-CoV-2)
emerged
in
late
December
2019.
Considering
the
important
role
of
gut
microbiota
maturation,
regulation,
and
induction
immune
system
subsequent
inflammatory
processes,
it
seems
that
evaluating
composition
COVID-19
patients
compared
with
healthy
individuals
may
have
potential
value
as
a
diagnostic
and/or
prognostic
biomarker
for
disease.
Also,
therapeutic
interventions
affecting
microbial
flora
open
new
horizons
treatment
accelerating
their
recovery.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
149, P. 112787 - 112787
Published: March 8, 2022
Coronavirus
disease
2019
(COVID-19)
is
an
acute
respiratory
infectious
caused
by
severe
syndrome
coronavirus
2
(SARS-CoV-2),
and
it
has
become
a
public
health
concern
worldwide.
In
addition
to
symptoms,
some
COVID‑19
patients
also
show
various
gastrointestinal
symptoms
even
consider
be
the
first
manifestation.
A
large
amount
of
evidence
shown
that
SARS-CoV-2
infection
could
disrupt
gut
microbiota
balance,
disorders
aggravate
condition
COVID-19
patients.
Therefore,
maintaining
balance
expected
potential
new
therapeutic
target
for
treating
COVID-19.
Traditional
Chinese
medicine
(TCM)
significant
effects
in
all
stages
prevention
treatment
It
can
adjust
ideal
intestinal
microecological
regulator.
This
review
summarizes
advantages
clinical
efficacy
TCM
expounds
on
relationship
between
microbiota,
mechanism
induced
SARS-CoV-2,
cytokine
storms
role
preventing
regulating
provide
research
ideas
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Sept. 6, 2022
Abstract
Coronavirus
disease
2019
(COVID-19),
primarily
a
respiratory
caused
by
infection
with
Severe
Acute
Respiratory
Syndrome
2
(SARS-CoV-2),
is
often
accompanied
gastrointestinal
symptoms.
However,
little
known
about
the
relation
between
human
microbiome
and
COVID-19,
largely
due
to
fact
that
most
previous
studies
fail
provide
high
taxonomic
resolution
identify
microbes
likely
interact
SARS-CoV-2
infection.
Here
we
used
whole-metagenome
shotgun
sequencing
data
together
assembly
binning
strategies
reconstruct
metagenome-assembled
genomes
(MAGs)
from
514
COVID-19
related
nasopharyngeal
fecal
samples
in
six
independent
cohorts.
We
reconstructed
total
of
11,584
medium-and
high-quality
microbial
MAGs
obtained
5403
non-redundant
(nrMAGs)
strain-level
resolution.
found
there
significant
reduction
strain
richness
for
many
species
gut
patients.
The
signatures
can
accurately
distinguish
cases
healthy
controls
predict
progression
COVID-19.
Moreover,
identified
set
nrMAGs
putative
causal
role
clinical
manifestations
revealed
their
functional
pathways
potentially
Finally,
demonstrated
main
findings
our
study
be
validated
three
presented
results
highlight
importance
incorporating
understanding
progression.
Antibiotics,
Journal Year:
2022,
Volume and Issue:
11(7), P. 857 - 857
Published: June 26, 2022
Enterococcus
are
opportunistic
pathogens
that
have
been
gaining
importance
in
the
clinical
setting,
especially
terms
of
hospital-acquired
infections.
This
problem
has
mainly
associated
with
fact
these
bacteria
able
to
present
intrinsic
and
extrinsic
resistance
different
classes
antibiotics,
a
great
deal
being
attributed
vancomycin-resistant
enterococci.
However,
other
aspects,
such
as
expression
virulence
factors
including
biofilm-forming
ability,
its
capacity
trading
genetic
information,
makes
this
bacterial
genus
more
capable
surviving
harsh
environmental
conditions.
All
characteristics,
some
reports
decreased
susceptibility
biocides,
all
described
literary
review,
allow
enterococci
longer
survival
ability
hospital
environment,
consequently
giving
them
opportunities
disseminate
settings
be
responsible
for
difficult-to-treat
Critical Care,
Journal Year:
2023,
Volume and Issue:
27(1)
Published: Feb. 23, 2023
Gut
microbiota
alterations
have
been
reported
in
hospitalized
COVID-19
patients,
with
reduced
alpha
diversity
and
altered
composition
related
to
respiratory
failure.
However,
data
regarding
gut
mortality
are
scarce.Rectal
swabs
for
analyses
were
collected
within
48
h
after
hospital
admission
(baseline;
n
=
123)
three-month
post-admission
(n
50)
a
subset
of
patients
included
the
Norwegian
SARS-CoV2
cohort
study.
Samples
analysed
by
sequencing
16S
rRNA
gene.
at
baseline
assessed
relation
need
intensive
care
unit
(ICU)
during
hospitalization.
The
primary
objective
was
investigate
whether
ICU-related
associated
60-day
mortality.Gut
(Shannon
index)
lower
requiring
ICU
hospitalization
than
those
managed
general
wards.
A
dysbiosis
index
representing
balance
enriched
taxa
compared
ward
including
decreased
abundance
butyrate-producing
microbes
enrichment
partly
oral
bacterial
flora,
independent
antibiotic
use,
dexamethasone
chronic
pulmonary
disease,
PO2/FiO2
ratio,
C-reactive
protein,
neutrophil
counts
or
creatinine
levels
(adjusted
p
<
0.001).
correlated
systemic
inflammation
univariate
(Hazard
ratio
3.70
[2.00-8.6],
0.001),
as
well
separate
adjustment
covariates.
At
follow-up,
remained
elevated
0.007).Although
our
should
be
regarded
exploratory
due
low
number
clinical
end
points,
they
suggest
that
could
poor
prognosis
severe
COVID-19.
Larger
studies
involvement
long-term
outcome
warranted.
Trial
registration
NCT04381819
.
Retrospectively
registered
May
11,
2020.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: May 2, 2023
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
has
posed
a
global
health
crisis.
Increasing
evidence
underlines
the
key
role
of
competent
immune
responses
in
resisting
SARS-CoV-2
infection
and
manifests
disastrous
consequence
host
dysregulation.
Elucidating
mechanisms
responsible
for
deregulated
immunity
COVID-19
may
provide
theoretical
basis
further
research
on
new
treatment
modalities.
Gut
microbiota
comprises
trillions
microorganisms
colonizing
human
gastrointestinal
tract
vital
homeostasis
gut-lung
crosstalk.
Particularly,
can
lead
to
disruption
gut
equilibrium,
condition
called
dysbiosis.
Due
its
regulatory
effect
immunity,
recently
received
considerable
attention
field
immunopathology.
Imbalanced
fuel
progression
through
production
bioactive
metabolites,
intestinal
metabolism,
enhancement
cytokine
storm,
exaggeration
inflammation,
regulation
adaptive
other
aspects.
In
this
review,
we
an
overview
alterations
patients,
their
effects
individuals’
susceptibility
viral
progression.
Moreover,
summarize
currently
available
data
critical
bidirectional
between
microbes
SARS-CoV-2-induced
pathology,
highlight
immunomodulatory
contributing
pathogenesis.
addition,
discuss
therapeutic
benefits
future
perspectives
microbiota-targeted
interventions
including
faecal
transplantation
(FMT),
bacteriotherapy
traditional
Chinese
medicine
(TCM)
treatment.
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 30, 2023
Thyroid
disorders
are
clinically
characterized
by
alterations
of
L-3,5,3’,5’-tetraiodothyronine
(T
4
),
L-3,5,3’-triiodothyronine
3
and/or
thyroid-stimulating
hormone
(TSH)
levels
in
the
blood.
The
most
frequent
thyroid
hypothyroidism,
hyperthyroidism,
and
hypothyroxinemia.
These
conditions
affect
cell
differentiation,
function,
metabolism.
It
has
been
reported
that
40%
world’s
population
suffers
from
some
type
disorder
several
factors
increase
susceptibility
to
these
diseases.
Among
them
iodine
intake,
environmental
contamination,
smoking,
certain
drugs,
genetic
factors.
Recently,
intestinal
microbiota,
composed
more
than
trillions
microbes,
emerged
as
a
critical
player
human
health,
dysbiosis
linked
microbiota
can
host
physiology
producing
metabolites
derived
dietary
fiber,
such
short-chain
fatty
acids
(SCFAs).
SCFAs
have
local
actions
intestine
central
nervous
system
immune
system.
Modulation
SCFAs-producing
bacteria
also
connected
metabolic
diseases,
obesity
diabetes.
In
this
review,
we
discuss
how
production
due
patients
could
be
related
disorders.
studies
reviewed
here
may
significant
interest
endocrinology
researchers
medical
practitioners.
Life,
Journal Year:
2023,
Volume and Issue:
13(10), P. 2023 - 2023
Published: Oct. 8, 2023
The
human
gut
microbiota
(GM)
is
a
complex
microbial
ecosystem
that
colonises
the
gastrointestinal
tract
(GIT)
and
comprised
of
bacteria,
viruses,
fungi,
protozoa.
GM
has
symbiotic
relationship
with
its
host
fundamental
for
body
homeostasis.
not
limited
to
scope
GIT,
but
there
are
bidirectional
interactions
between
other
organs,
highlighting
concept
"gut-organ
axis".
Any
deviation
from
normal
composition
GM,
termed
"microbial
dysbiosis",
implicated
in
pathogenesis
various
diseases.
Only
few
studies
have
demonstrated
modifications
disease
phenotypes,
it
still
unknown
whether
an
altered
contributes
or
simply
reflects
status.
Restoration
probiotics
prebiotics
been
postulated,
evidence
effects
limited.
Prebiotics
substrates
"selectively
utilized
by
microorganisms,
conferring
health
benefit".
This
study
highlights
vital
organs
demonstrates
dysbiosis
emergence
certain
representative
Finally,
this
article
focuses
on
potential
as
target
therapy
manipulate
presents
gaps
literature
research.